Belanoff Joseph K's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Jun 2, 2026
- Accession no.
- 0001193125-26-253459
- Filed
- Jun 2, 2026
- Trade date
- May 29-Jun 1, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $895.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Belanoff Joseph KCIK 0001286199 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | GGiftDisposed | −300,000 | $0.00 | $0 | 2,578,326 | Indirect | |
| May 29, 2026 | Common Stock | GGiftAcquired | +150,000 | $0.00 | $0 | 150,000 | Indirect | |
| May 29, 2026 | Common Stock | GGiftAcquired | +150,000 | $0.00 | $0 | 150,000 | Indirect | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −12,837 | $69.74 | −$895,252.38 | 2,565,489 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.